Video Experimental Relacionado
Updated: May 5, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.3K
La base genética para las decisiones de tratamiento del cáncer
Janet E Dancey1, Philippe L Bedard, Nicole Onetto
1Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
Cell
|February 7, 2012
Resumen
La medicina personalizada contra el cáncer utiliza el conocimiento genético para atacar mutaciones en el cáncer, moviendo el tratamiento de conjeturas a decisiones basadas en la evidencia. Este marco es crucial para mejorar los resultados de los pacientes en medio del cáncer.
Área de la Ciencia:
- Oncología Oncología Oncología.
- La genómica es la genómica.
- La medicina traslacional es la medicina traslacional.
Sus antecedentes:
- La medicina personalizada contra el cáncer se basa en la comprensión de las mutaciones genéticas del cáncer y las terapias dirigidas.
- Los avances en la genética del cáncer, la tecnología y el desarrollo de medicamentos crean una oportunidad para un nuevo marco clínico.
Objetivo del estudio:
- Establecer un marco de ensayos clínicos y de investigación para la medicina personalizada contra el cáncer.
- Para la transición de las decisiones de tratamiento del cáncer de enfoques heurísticos a estrategias basadas en la evidencia.
Principales métodos:
- Integración de las pruebas genómicas en los procesos de toma de decisiones sobre el tratamiento del cáncer.
- Desarrollo de un marco para ensayos clínicos e investigación en oncología personalizada.
Principales resultados:
- El estudio describe la necesidad y el potencial de un marco estructurado para la medicina personalizada contra el cáncer.
- Destaca el imperativo científico y ético para avanzar en enfoques personalizados.
Conclusiones:
- La implementación de un marco sólido es esencial para obtener todos los beneficios de la medicina personalizada contra el cáncer.
- Abordar los desafíos en la integración de las pruebas genómicas es clave para mejorar los resultados de los pacientes con cáncer.
Videos de Conceptos Relacionados
02:18Cancer
51.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870